sublingual delivery glp-1 receptor agonists Frontiers Peptide GLP-1 receptor agonists: From
Description
It doesn't outperform injectables on raw weight loss numbers, but it removes a massive barrier for a large segment of the population
Back Nathan, DM, Schreiber, E, Fogel, H, et al (Feb 1992) 'Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects', Journal Diabetes Care , 15/2, 270-6
Viking Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company, is advancing a dual GLP-1/GIP agonist, VK2735, for treating obesity for both subcutaneous and oral administration
doi: 10.2337/db07-1369
examined how chronic hepatitis B virus (HBV)- related gut microbiota imbalance affects miR-1925p and GLP-1 expression in 2018
Collectively, this model explained about 21.4% of variance in percentage BMI loss (adjusted R 2 )
